Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Pfizer-INDovation-program"

3 News Found

Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant
Startup | November 11, 2024

Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant

The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem
Startup | September 05, 2025

DPIIT signs MoU with Pfizer to strengthen India’s healthcare innovation ecosystem

Under the partnership, the Pfizer INDovation program will empower DPIIT-recognized startups with grants of up to Rs. 60 lakhs each, along with a tailored 18-month incubation program delivered by Social Alpha

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India
Startup | February 27, 2024

Pfizer joins hands with NIPER (Ahmedabad) to support Healthcare Innovation in India

Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups

Latest Stories

Glenmark initiates multi-country Phase 3 clinical trial for Envafolimab in resectable Stage III NSCLC

Poly Medicure to acquire 90% stake in PendraCare Group for € 18.3 million

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging